University of Texas Southwestern Medical Center Endocrinology, Diabetes, and Metabolism

Topics

• Diabetes Treatment and Management 370
• Hormonal Regulation and Hypertension 304
• Diabetes Management and Research 142
• Cholesterol and Lipid Metabolism 110
• Nuclear Structure and Function 110
• Salivary Gland Tumors Diagnosis and Treatment 106
• Regulation of Appetite and Obesity 101
• Lipoproteins and Cardiovascular Health 99
• Kidney Stones and Urolithiasis Treatments 85
• Bone health and osteoporosis research 61
• Thyroid Cancer Diagnosis and Treatment 61
• Diabetes, Cardiovascular Risks, and Lipoproteins 53

Most cited

1. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.

   The New England journal of medicine · 2023 · 2,447 citations · Ildiko Lingvay

2. Once-Weekly Semaglutide in Adults with Overweight or Obesity.

   The New England journal of medicine · 2021 · 3,798 citations · Ildiko Lingvay, Julio Rosenstock

3. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.

   The New England journal of medicine · 2021 · 1,567 citations · Julio Rosenstock

4. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement.

   The lancet. Diabetes & endocrinology · 2023 · 684 citations · Julio Rosenstock

5. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials.

   The lancet. Diabetes & endocrinology · 2021 · 1,298 citations · Julio Rosenstock

6. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.

   Lancet (London, England) · 2021 · 1,134 citations ·